AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY (EIN 521850793) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1993

Legal Domicile

Principal Officer

COREY CUTLER

Phone

3123216820

Tax Period

2023-01-01 to 2023-12-31

AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY, founded in 1993, is a community nonprofit in the Medical Research sector that reported $8.1M in total revenue in fiscal year 2023. Revenue grew 11% year-over-year, indicating healthy expansion.

Mission

IMPROVE BLOOD AND MARROW TRANSPLANTATION AND RELATED CELLULAR THERAPIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $2,157,455

Program Service Revenue $5,268,135

Investment Income $233,568

Other Revenue $448,635

TOTAL REVENUE $8,107,793

Expense Breakdown

Grants Paid $930,935

Salaries & Benefits $31,750

Fundraising Expenses $0

Program Expenses $7,445,968

Other Expenses $7,357,148

TOTAL EXPENSES $8,319,833

Year-over-Year Comparison

	2023	2022	Change
Revenue	$8,107,793	$7,320,416	+0.1%
Expenses	$8,319,833	$6,803,644	+0.2%
Net Income	$-212,040	$516,772	-1.4%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$30,000

Total Directors

$31,750

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BRENDA SANDMAIER MD PRES	UNTIL 2/2023, THEN PAST PRESIDENT	3.00	Officer Director	$0	$0	$0
MIGUEL-ANGEL PERALES MD VP	UNTIL 2/2023, THEN PRESIDENT	3.00	Officer Director	$0	$0	$0
STELLA DAVIES	PAST PRESIDENT UNTIL 2/2023	3.00	Officer Director	$0	$0	$0
CORY CUTLER MD VP UNTIL	2/2023, THEN PRESIDENT ELECT	3.00	Officer Director	$0	$0	$0
DAVID PORTER MD	VICE PRESIDENT AS OF 2/2023	3.00	Officer Director	$30,000	$0	$30,000
AMRIAT KRISHNAN	SECRETARY UNTIL 2/2023	3.00	Officer Director	$0	$0	$0
MEHDI HAMADANI MD	SECRETARY AS OF 2/2023	3.00	Officer Director	$0	$0	$0
UDAY POPAT MD	TREASURER	3.00	Officer Director	$0	$0	$0
BETTY HAMILTON MD	DIRECTOR	3.00	Director	$750	$0	$750
NANDITA KHERA MD	DIRECTOR	3.00	Director	$0	$0	$0
DIANNA HOWARD MD	DIRECTOR	3.00	Director	$0	$0	$0
BRIAN BETTS MD	DIRECTOR	3.00	Director	$0	$0	$0
ALAN HANASH MD PHD	DIRECTOR	3.00	Director	$0	$0	$0
SUNG-YUN PAI MD	DIRECTOR	3.00	Director	$0	$0	$0
KIRSTEN WILLIAMS	DIRECTOR	3.00	Director	$0	$0	$0
LORI MUFFLY MD	DIRECTOR	3.00	Director	$0	$0	$0
NIRALI SHAH MD	DIRECTOR	3.00	Director	$0	$0	$0
LESLIE KEAN	DIRECTOR UNTIL 2/2023	3.00	Director	$1,000	$0	$1,000
SHALINI SHENOY	DIRECTOR UNTIL 2/2023	3.00	Director	$0	$0	$0
ENEIDA NEMECEK	DIRECTOR UNTIL 2/2023	3.00	Director	$0	$0	$0
ANDRE WILLIAMS	EXECUTIVE DIRECTOR	40.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$8,107,793	$8,319,833	$11,968,853	$-212,040
2022	$7,565,810	$6,879,329	$11,031,172	$686,481
2021	$5,528,435	$4,797,386	$11,425,659	$731,049
2020	$5,769,745	$4,637,330	$9,607,006	$1,132,415
2020	$5,776,958	$4,406,527	$9,647,006	$1,370,431
2019	$5,433,015	$4,370,323	$8,263,852	$1,062,692

AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY